Multivariate analysis of risk factors of PFS and OS of DLBCL patients treated with R-CHOP
| Risk factor . | PFS . | OS . | ||
|---|---|---|---|---|
| Hazard ratio (CI) . | P . | Hazard ratio (CI) . | P . | |
| MYC+ | 3.28 (1.49-7.21) | .003 | 2.98 (1.28-6.95) | .011 |
| IPI ≥ 3 | 2.69 (1.48-4.86) | .001 | 3.29 (1.68-6.46) | .001 |
| Non-GCB phenotype* | 1.86 (1.04-3.34) | .038 | — | NS |
| Bone marrow DLBCL+ | 3.74 (1.67-8.36) | .001 | 4.06 (1.72-9.58) | .001 |
| Risk factor . | PFS . | OS . | ||
|---|---|---|---|---|
| Hazard ratio (CI) . | P . | Hazard ratio (CI) . | P . | |
| MYC+ | 3.28 (1.49-7.21) | .003 | 2.98 (1.28-6.95) | .011 |
| IPI ≥ 3 | 2.69 (1.48-4.86) | .001 | 3.29 (1.68-6.46) | .001 |
| Non-GCB phenotype* | 1.86 (1.04-3.34) | .038 | — | NS |
| Bone marrow DLBCL+ | 3.74 (1.67-8.36) | .001 | 4.06 (1.72-9.58) | .001 |
NS indicates not significant; and —, not applicable.
Not available in 4 MYC− cases.